BRPI9813397A - formulação medicinal em aerossol e produto medicinal. - Google Patents

formulação medicinal em aerossol e produto medicinal.

Info

Publication number
BRPI9813397A
BRPI9813397A BRPI9813397A BRPI9813397A BRPI9813397A BR PI9813397 A BRPI9813397 A BR PI9813397A BR PI9813397 A BRPI9813397 A BR PI9813397A BR PI9813397 A BRPI9813397 A BR PI9813397A BR PI9813397 A BRPI9813397 A BR PI9813397A
Authority
BR
Brazil
Prior art keywords
medicinal
aerosol formulation
drug
product
propellant
Prior art date
Application number
BRPI9813397A
Other languages
English (en)
Inventor
Yvonne Mary Beatrice King
Kanwaljit Singh Claire
Original Assignee
Minnesota Mining & Mfg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Minnesota Mining & Mfg filed Critical Minnesota Mining & Mfg
Publication of BRPI9813397A publication Critical patent/BRPI9813397A/pt
Publication of BRPI9813397B1 publication Critical patent/BRPI9813397B1/pt
Publication of BRPI9813397B8 publication Critical patent/BRPI9813397B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

patente de invenção: <b>''composições farmacêuticas em aerossol"<d> formulação medicinal em aerossol compreendendo partículas de propelente de uma primeira droga suspensa em propelente e uma segunda droga completamente dissolvida na formulação em aerossol.
BRPI9813397 1997-12-08 1998-11-20 formulação medicinal em aerossol e produto medicinal. BRPI9813397B8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9725984A GB2332372B (en) 1997-12-08 1997-12-08 Pharmaceutical aerosol compositions
PCT/GB1998/003488 WO1999029296A1 (en) 1997-12-08 1998-11-20 Pharmaceutical aerosol compositions

Publications (3)

Publication Number Publication Date
BRPI9813397A true BRPI9813397A (pt) 2000-10-10
BRPI9813397B1 BRPI9813397B1 (pt) 2011-08-23
BRPI9813397B8 BRPI9813397B8 (pt) 2021-07-06

Family

ID=10823304

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI9813397 BRPI9813397B8 (pt) 1997-12-08 1998-11-20 formulação medicinal em aerossol e produto medicinal.

Country Status (11)

Country Link
EP (1) EP1037604B1 (pt)
JP (1) JP5384776B2 (pt)
AT (1) ATE287699T1 (pt)
AU (1) AU759746B2 (pt)
BR (1) BRPI9813397B8 (pt)
CA (1) CA2311450C (pt)
DE (1) DE69828817T2 (pt)
ES (1) ES2234165T3 (pt)
GB (1) GB2332372B (pt)
PT (1) PT1037604E (pt)
WO (1) WO1999029296A1 (pt)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RO119116B1 (ro) * 1995-04-14 2004-04-30 Glaxo Wellcome Inc. Inhalator pentru dozarea salmeterolului
GB9616237D0 (en) 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
US6423298B2 (en) 1998-06-18 2002-07-23 Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceutical formulations for aerosols with two or more active substances
US6479035B1 (en) * 1999-09-11 2002-11-12 Smithkline Beecham Corporation Pharmaceutical formulation of fluticasone propionate
ATE291898T1 (de) * 1999-12-24 2005-04-15 Glaxo Group Ltd Pharmazeutische aerosol formulierung enthaltend salmeterol und fluticason
US20040191176A1 (en) * 2003-03-28 2004-09-30 Kaplan Leonard W Formulations for treatment of pulmonary disorders
DE102006053374A1 (de) * 2006-02-09 2007-08-16 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmazeutische Formulierung für Aerosole mit zwei oder mehr Wirkstoffen und mindestens einer oberflächenaktiven Substanz
EP2077132A1 (en) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Dispensing device, storage device and method for dispensing a formulation
EP2662472B1 (de) 2009-03-31 2019-02-27 Boehringer Ingelheim International Gmbh Verfahren zur Beschichtung einer Oberfläche eines Bauteils
EP3508239B1 (de) 2009-05-18 2020-12-23 Boehringer Ingelheim International GmbH Adapter, inhalationseinrichtung und zerstäuber
SG181050A1 (en) 2009-11-25 2012-07-30 Boehringer Ingelheim Int Nebulizer
JP5658268B2 (ja) 2009-11-25 2015-01-21 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ネブライザ
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
EP2512438B1 (en) * 2009-12-16 2017-01-25 3M Innovative Properties Company Formulations and methods for controlling mdi particle size delivery
WO2011160932A1 (en) 2010-06-24 2011-12-29 Boehringer Ingelheim International Gmbh Nebulizer
WO2012130757A1 (de) 2011-04-01 2012-10-04 Boehringer Ingelheim International Gmbh Medizinisches gerät mit behälter
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
WO2013152894A1 (de) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Zerstäuber mit kodiermitteln
PL2835146T3 (pl) 2013-08-09 2021-04-06 Boehringer Ingelheim International Gmbh Nebulizator
WO2015018904A1 (en) 2013-08-09 2015-02-12 Boehringer Ingelheim International Gmbh Nebulizer
BR112016023983B1 (pt) 2014-05-07 2022-10-18 Boehringer Ingelheim International Gmbh Contentor para um nebulizador, nebulizador para um fluido e método para conectar um contentor a um dispositivo indicador
US10722666B2 (en) 2014-05-07 2020-07-28 Boehringer Ingelheim International Gmbh Nebulizer with axially movable and lockable container and indicator
WO2015169759A1 (en) 2014-05-07 2015-11-12 Boehringer Ingelheim International Gmbh Nebulizer and container
US11877848B2 (en) 2021-11-08 2024-01-23 Satio, Inc. Dermal patch for collecting a physiological sample
US12053284B2 (en) 2021-11-08 2024-08-06 Satio, Inc. Dermal patch for collecting a physiological sample
US11452474B1 (en) 2021-04-14 2022-09-27 Satio, Inc. Dual lever dermal patch system
US12048543B2 (en) 2021-11-08 2024-07-30 Satio, Inc. Dermal patch for collecting a physiological sample with removable vial
US12023156B2 (en) 2021-10-13 2024-07-02 Satio, Inc. Dermal patch for collecting a physiological sample
US11964121B2 (en) 2021-10-13 2024-04-23 Satio, Inc. Mono dose dermal patch for pharmaceutical delivery

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2094266C (en) * 1990-10-18 1999-06-01 Robert K. Schultz Aerosol formulations of beclomethasone-17,21-dipropionate
ES2079210T3 (es) * 1991-12-12 1996-01-01 Glaxo Group Ltd Formulacion farmaceutica de aerosol.
IL104068A (en) * 1991-12-12 1998-10-30 Glaxo Group Ltd Pharmaceutical preparations in a spray without surfactant containing 1, 1, 1, 2 tetrafluoroethane or 1,1,2,3,3 petafluor N propane as propellant
US5589156A (en) * 1994-05-02 1996-12-31 Henry; Richard A. Prilocaine and hydrofluourocarbon aerosol preparations
GB9425160D0 (en) * 1994-12-10 1995-02-08 Glaxo Group Ltd Medicaments
AU3453897A (en) * 1996-07-08 1998-02-02 Rhone-Poulenc Rorer Limited Medicinal cyclosporin-a aerosol solution formulation
RU2218152C2 (ru) * 1998-06-18 2003-12-10 Берингер Ингельхайм Фармасьютикэлс, Инк. Фармацевтическая композиция для аэрозолей с двумя или большим количеством действующих веществ

Also Published As

Publication number Publication date
GB2332372A (en) 1999-06-23
AU1248699A (en) 1999-06-28
BRPI9813397B1 (pt) 2011-08-23
EP1037604B1 (en) 2005-01-26
ES2234165T3 (es) 2005-06-16
WO1999029296A1 (en) 1999-06-17
EP1037604A1 (en) 2000-09-27
JP2001525354A (ja) 2001-12-11
DE69828817T2 (de) 2006-05-18
CA2311450C (en) 2009-05-05
ATE287699T1 (de) 2005-02-15
JP5384776B2 (ja) 2014-01-08
GB2332372B (en) 2002-08-14
PT1037604E (pt) 2005-05-31
BRPI9813397B8 (pt) 2021-07-06
AU759746B2 (en) 2003-05-01
GB9725984D0 (en) 1998-02-04
DE69828817D1 (de) 2005-03-03
CA2311450A1 (en) 1999-06-17

Similar Documents

Publication Publication Date Title
BRPI9813397B8 (pt) formulação medicinal em aerossol e produto medicinal.
ATE343374T1 (de) Fluticasonpropionat arzneizubereitung
DE60019167D1 (de) Pharmazeutische aerosol formulierung enthaltend salmeterol und fluticason
NZ298169A (en) Aerosol drug formulation; comprises hydrofluoroalkane propellant, medicament for inhalation and a surfactant
BR1100339A (pt) Formulações de aerossol em solução de beclometasona
GEP20053420B (en) Sustained Release Ranolanolazine Formulation
NO307864B1 (no) Farmasøytisk aerosolformulering, boks og doseringsinhalator
HK1042444A1 (zh) 藥用噴霧製劑
HUP0102468A2 (hu) Nyomás alatti dózisadagoló inhaláló berendezés és aeroszol formájú gyógyászati készítmények
EE04021B1 (et) 7a-( -aminoalküül)östratrieenid, nende valmistamise meetod, 7a-( -aminoalküül)östratrieene sisaldavad farmatseutilised preparaadid ja nende kasutamine ravimite valmistamiseks
ES2107203T3 (es) Una formulacion de aerosol que contiene un adyuvante de dispersion derivado de un diol-diacido.
NO990454L (no) Aerosol-materiale
NO20010277L (no) Benzocykloheptener, fremgangsmÕte for fremstilling derav, farmasøytiske preparater inneholdende disse, og deres anvendelse for fremstilling av medikamenter
ATE180665T1 (de) Pharmazeutische zusammensetzungen und vorrichtungen zu deren verabreichung
NO305286B1 (no) Kinoksalinforbindelser, farmas°ytiske preparater som omfatter dem, og anvendelse derav for fremstilling av medikamenter
NO308527B1 (no) Substituerte 2-naftoylguanidiner, deres anvendelse for fremstilling av et medikament samt legemidler og preparater inneholdende forbindelsene
ATE202936T1 (de) Chlorfluorkohlenwasserstoff freie aerosol- arzneizubereitungen enthaltend mometasonfuroat
WO2001082868A3 (en) A medicinal aerosol formulation
NO308737B1 (no) Diarylalkanderivater inneholdende en alisyklisk gruppe, deres anvendelse ved fremstilling av et legemiddel, og farmasøytiske preparater inneholdende disse
NO308793B1 (no) Ortosubstituerte benzoylguanidiner, deres anvendelse for fremstilling av medikamenter samt legemidler inneholdende forbindelsene
ATE286716T1 (de) Pharmazeutische formulierungen enthaltend salmeterol
MX9707238A (es) Formulaciones en aerosol de butixocort.
ITBA920007A0 (it) Formulazioni farmaceutiche per la somminstrazione sistemica per via nasale degli ormoni sessuali femminili naturali e di ormoni ad attivita&#39; estrogenica e/o progestativa sia naturali che di sintesi.
MX9707073A (es) Preparaciones de aerosol de prilocaina e hidrofluorocarbono.
DK67493D0 (da) Biologisk aktivt produkt og fremgangsmaade til fremstilling deraf samt farmaceutiske og kosmetiske praeparater indeholdende produktet